Clinical Trial Update: Decitabine With GCLAM for Adults With Newly Diagnosed, Relapsed, or Refractory AML or High-Risk MDS [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating decitabine with the GCLAM regimen in adults with newly diagnosed, relapsed, or refractory acute myeloid leukemia or high-r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• decitabine with GCLAM

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Mixed Phenotype Acute Leukemia, Previously Treated Myelodysplastic Syndrome | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-03-17